Stockbroking | Wealth Management | Corporate Advice

x

Resizing text on the web

To increase or decrease the magnification of a web page, press Ctrl and '+' (plus) to zoom in or Ctrl and '-' (minus) to zoom out. To return the page to its original size, press Ctrl + 0.

You can also scroll the mouse wheel up and down while holding Ctrl to increase/decrease zoom level.

Blog

FY17 reporting season preview

Andrew Tang

An end to the earnings drought

FY17 reporting season kicks off in earnest mid-August and according to the latest IBES consensus earnings estimates, EPS growth for the S&P/ASX200 is forecast at 13% in FY17, slightly down from 13.6% at the end of 1H17. Pleasingly this would still mark the end of the earnings recession after two straight years of contraction. We are confident that the improvement in the economic outlook will translate to earnings over the next 12-18 months so long as the positive conditions are reflected elsewhere (outside of Resources). With this in mind, we think outlook commentary and how management chooses to deploy capital may be as important as reported numbers.

The growth versus value conundrum

The prospect of policy gridlock in the US and low levels of global wage inflation have again resurfaced dis-inflationary fears. This has prompted investors to seek safety in the quality and yield trades that have been so profitable for many over the past two years. Valuations therefore remain extended and the divergence between 'growth' and 'value' stocks has again widened. High valuations make for high expectations. We are wary of high PE stocks with even the slightest earnings risk (CSL, DMP, COH) – as demonstrated through the May 'confession' season, stocks that miss the mark continue to underperform. The PE divergence also presents opportunities in overlooked areas of the market where we see earnings upside potential (LOV, JBH, CLH).

Turning 'soft' data into earnings

While a lot has been said of the weak growth in the Australian economy in Q1 2017, forward-looking indicators of business activity continue to indicate broad expansion in activity. After a prolonged period of cost-out and consolidation, it is encouraging to see a sustained pick-up in business conditions and sentiment which we expect to translate into an improvement in earnings. The translation of improving 'soft' survey data into earnings growth is necessary to support the high valuations commanded by the market. Falling payout ratios suggest that, perhaps, corporate Australia is finally ready to revive capital expenditure and investment in growth.

Morgans surprise or disappoint candidates

We highlight our key candidates that may surprise or disappoint during the upcoming August results season:

  • Potential earnings surprises – Amcor (AMC), Reliance Worldwide (RWC), JB HiFi (JBH), Lovisa (LOV), Webjet (WEB), ResMed (RMD), Bapcor (BAP)
  • Likely to see positive outlook statements – Ramsay Healthcare (RHC), Healthscope (HSO), Collection House (CLH), Sirtex (SRX), EBOS (EBO)
  • Potential for positive capital management – BHP (BHP) and Rio Tinto (RIO)
  • Potential earnings disappointments – Coca-Cola Amatil (CCA), Blackmores (BKL), Pact Group (PGH), Admedus (AHZ)
  • Possible soft outlook – Telstra (TLS), TPG Telecom (TPM), Cedar Woods (CWP), Mantra (MTR)
  • Vulnerable high PE stocks – Ansell (ANS), CSL (CSL), Cochlear (COH), Domino's (DMP) 

More information

Morgans clients can login to view our detailed Australia Strategy – FY17 reporting season preview. Alternatively, please contact your nearest Morgans office for access.

Disclaimer(s): Analyst may own shares is some or all of the companies mentioned.

The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.